News
Novavax (NasdaqGS:NVAX) recently amended its collaboration agreement with Takeda, enhancing its revenue potential through a new upfront payment structure and future royalties. These developments, ...
Novavax announces significantly improved terms for collaboration and license pact with Takeda for Nuvaxovid in Japan: Gaithersburg, Maryland Tuesday, May 6, 2025, 14:00 Hrs [IST] ...
13h
IFLScience on MSNA blanket requirement for placebo-controlled trials threatens research ethics and vaccine access, it’s being argued.A blanket requirement for placebo-controlled trials threatens research ethics and vaccine access, it’s being argued.
Robert F. Kennedy Jr., who oversees the FDA, intends to set new regulatory standards vaccine manufacturers couldn’t possibly ...
Health experts raise concerns about the rise in vaccine skepticism and hesitancy as a bill criminalizing certain vaccines circulates in the state Legislature. A group of Minnesota House Republicans ...
Dr. Vinay Prasad succeeds Dr. Peter Marks, who left the role of leader of the FDA’s Center for Biologics Evaluation and ...
Dr. Howard Forman reflects on heartening new evidence for the effectiveness of the HPV vaccine—and troubling signs of vaccine ...
The HHS will begin to require placebo-controlled trials for all new vaccines, which will radically alter the testing process.
The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics ...
(CTN News) – The Food and Drug Administration (FDA) has elected to appoint a new director for the Center for Biologics ...
In late April, Summit Therapeutics revealed interim OS data from HARMONi-2 for its PD-1/VEGF bispecific antibody, ivonescimab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results